Kidney Cancer Study Puts Circulating Tumor DNA Assay to Test
The study will examine whether Natera’s circulating tumor DNA assay can distinguish between recurring and nonrecurring cases of kidney cancer.
Read More
Search Results for: lung cancer
OGT Expands Custom NGS Cancer Panel Content and Readies Enhanced Software for Release
The expanded SureSeq myPanel next-generation sequencing custom cancer panel now covers 120 fully optimized cancer-related genes.
Read More
Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe
The company anticipates a $10 million annual European market, with $1 million in annual addressable sales potential from its local partner it Italy.
Read More
Bio-Rad Launches Anti-Idiotypic Antibodies Targeting Pembrolizumab and Nivolumab
Anti-idiotypic antibodies will enable monitoring of for pembrolizumab and nivolumab levels in cancer patients undergoing treatment.
Read MorePredicting the Effectiveness of Anti-PD-L1 Therapy
A potential alternative to immunohistochemistry for predicting patients’ response to anti-PD-L1 therapy is to use testing based on the droplet digital polymerase chain reaction technique to detect changes in the mRNA expression levels in patients’ blood.
Read More